期刊文献+

不同宫颈组织中PIK3CA、PTEN和p16蛋白表达及其与HPV16/18感染的关系 被引量:5

Correlation between PIK3CA,PTEN and p16 Protein Expression and Human Papillomavirus Infection in Different Cervical Tissues
下载PDF
导出
摘要 目的探讨PIK3CA、PTEN和p16蛋白在人正常宫颈上皮、宫颈上皮内瘤变(cervical intraepitheli-al neoplasia,CIN)和宫颈鳞癌组织中的表达,以及PIK3CA、PTEN和p16蛋白表达与人乳头瘤病毒(humanpapillomavirus,HPV)感染之间的关系。方法采用免疫组织化学二步法在22例健康者宫颈组织、72例宫颈上皮内瘤变(cervical intraepithelial neoplasia,CIN)和30例宫颈鳞癌组织中检测PIK3CA、PTEN和p16蛋白的表达,显色原位杂交方法检测高危型HPV16/18的感染。结果 PIK3CA和p16蛋白表达阳性率和HPV16/18的感染率均随着宫颈上皮逐渐恶变而上升,PTEN蛋白表达却呈现相反的结果。PIK3CA、PTEN、p16蛋白和HPV16/18的感染率在宫颈鳞癌和CINⅡ~Ⅲ组中的表达分别与对照组和CINⅠ组相比,差异均有统计学意义(P<0.05)。在宫颈上皮内瘤变组织中,39例(76.47%)CINⅡ~Ⅲ中显示PIK3CA阳性,仅有9例(42.86%)CINⅠ中显示PIK3CA阳性,两组间差异有统计学意义(P=0.006),而PTEN和p16蛋白在宫颈上皮内瘤变不同组别中相比差异均无统计学意义。在81例CINⅡ~Ⅲ和鳞癌组织中,PIK3CA和p16蛋白呈显著正相关关系(P=0.000,r=0.544)。PIK3CA、p16蛋白与PTEN蛋白表达之间,两者均呈显著负相关(P<0.05)。HPV16/18阳性的47例标本中,PIK3CA和p16蛋白几乎均呈阳性表达,呈显著正相关(P<0.01),但PTEN蛋白却有37例呈阴性表达,无显著相关(P=0.116)。结论 PIK3CA、PTEN、p16蛋白表达以及高危型HPV感染与宫颈癌的发生发展均密切相关。PIK3CA、PTEN、p16蛋白和高危型HPV感染联合检测,可作为宫颈癌早期癌变的分子标志物。高危型HPV感染可能有助于PIK3CA和p16蛋白的高表达。 Objective To evaluate correlations between PIK3CA,PTEN and p16 protein expression,and human papillomavirus(HPV) infection in the normal cervix epithelium,cervical intraepithelial neoplasia(CIN) and cervix squamous cell carcinoma(SCC).Methods The immunohistochemical staining PV-9000 method was used to detect the expression of PIK3CA,PTEN and p16 protein and high-risk HPV16/18 infection was detected by chromogenic in situ Hybridization in 30 cases of SCC(SCC group),21 cases of CIN Ⅰ(CINⅠgroup),51 cases of CINⅡ~Ⅲ(CIN Ⅱ~Ⅲ group),and 22 cases of normal cervix tissues(control group).Results PIK3CA and p16 protein expression rate and HPV16/18 infection rate were gradually increased,but PTEN protein expression rate was gradually decreased along with the malignant transformation of cervical epithelium.The differences of PIK3CA,PTEN,p16 protein and HPV16/18 prevalence in cervical cancer and CIN Ⅱ ~ Ⅲ group were significant,compared with control group or CIN Ⅰ group,(P0.05).In cervical intraepithelial neoplasia tissues,PIK3CA positive rate(76.47%,39 cases) in CIN Ⅱ ~ Ⅲwas significant higher than that in CIN Ⅰ(42.86%,9 cases),P=0.006.PTEN and p16 protein positive rates were similar in different CIN groups.In 81 cases of human CIN Ⅱ ~ Ⅲ and squamous cell carcinoma,PIK3CA showed a significant positive correlation to p16 protein(P=0.000,r=0.544).PIK3CA,p16 protein were negative correlated to PTEN protein expression(P0.05).In 47 HPV16/18 positive specimens,PIK3CA,and p16 protein expressions almost were positive correlation(P0.01),but 37 cases of PTEN protein expression were negative,(P=0.116).Conclusion PIK3CA,PTEN,p16 protein expression and high-risk HPV infection were closely related to the development of cervical cancer.Combined detection of PIK3CA,PTEN,p16 protein and high-risk HPV might be a molecular marker for SCC early diagnosis.The over-expressions of PIK3CA and p16 protein were related with high-risk human papillomavirus infection.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2012年第2期189-194,共6页 Cancer Research on Prevention and Treatment
关键词 宫颈癌 PIK3CA P16 PTEN 人乳头瘤病毒 Cervical cancer PIK3CA PTEN p16 protein Human papillomavirus
  • 相关文献

参考文献15

  • 1Cui B, Zheng B, Zhang X,et al. Mutation of PIK3CA: possible risk factor for cervical carcinogenesis in older women[J]. Int J Oncol, 2009,34 (2) : 409-416.
  • 2Woenckbaus J, Steger K,Sturm K, et al. Prognostic value of PIK3CA and phosphorylated AKT expression in ovarian cancer [J]. VirchowsArcb,2007,450(4) :387-395.
  • 3Ma YY,Wei S], Lin YC,et al. PIK3CA as an oncogene in cervical caneer[J]. Oncogene,2000,19(23) : 2739-2744.
  • 4Goto T, Takano M, Sasa H, et al. Clinical significance of immu-nocytochemistry for PIK3CA as a carcinogenesis-related marker on liquid-based cytology in cervical intraepithelial neoplasia [J]. Oncol Rep,2006,15(2) :387-391.
  • 5Lee JS, Choi YD, Lee JH, et al. Expression of PTEN in the progression of cervical neoplasia and its relation to tumor behavior and angiogenesis in invasive squamous cell carcinoma [J]. J Surg Oncol, 2006,93 (3) : 233-240.
  • 6Cheung TH, Lo KW, Yim SF, et al. Epigenetic and genetic alternation of PTEN in cervical neoplasm[,J]. Gynecol Oncol, 2004,93(3) :621-627.
  • 7Tsai CH, Yang CC, Chou LS, et al. The correlation between alternation of p16 gene and clinical status in oral squamous cell carcinoma[J]. J Oral Pathol Meal,2001,30(9) :527-531.
  • 8Kurshumliu F, Thorns C, Gashi-Luci L. pI6INK4A in routine practice as a marker of cervical epithelial neoplasia[J]. Gynecol Oncol, 2009,115(1 ) : 127-131.
  • 9Mulvany NJ,Allen DG,Wilson SM. Diagnostic utility of pl6INK4a: a reappraisal of its use in cervical biopsies [J]. Pathology, 2008,40(4) ..335-344.
  • 10Jedpiyawongse A, Homcha -era P, Karalak A, et al. Immuno-histochemical overexpression of p16 protein associated with cervical cancer in Thailand[J]. Asian Pac J Cancer Prev,2008, 9(4) :625-630.

二级参考文献13

  • 1牛晓宇,彭芝兰,王和.RNA干涉抑制宫颈癌CaSki细胞株HPV16 E6基因的研究[J].癌症,2004,23(11):1257-1262. 被引量:27
  • 2Giarre M,Caldeira S,Malanchi I,et al.Induction of pRb degradation by the human papillomavirus type16 E7 protein is essential to efficiently overcome P16INK4(A)-imposed G1 cell cycle arrest[J].J Virol,2001,75(10):4705-4712.
  • 3Sherr C J.Cancer cell cycles[J].Science,1996,274(5293):1672-1680.
  • 4Li Y,Nichols M A,Shay J W,et al.Transcriptional repression of the D-type cyclin dependent kinase inhibitor p16 by retinoblastoma susceptibility gene product pRb[J].Cancer Res,1994,54 (23):6078-6082.
  • 5Sakaguchi M,Fujii Y,Hirabayashi H,et al.Inversely correlated expression of p16 and Rb protein in non-small cell lung cancers:an immunohistochemical study[J].Int J Cancer,1996 65(4):442-445.
  • 6Murphy N,Ring M,Killalea A G,et al.P16^INK4A as a marker for cervical dyskaryosis:CIN and cGIN in cervical biopsies and ThinPrep^TM smears[J].J Clin Pathol,2003,56(1):56-63.
  • 7Steck P A,Pershouse M A,Jasser S A,et al.Identification of a candidate tumor suppressor gene,MMAC1,at chromosome 10q23.3 that is mutated in multiple advanced cancers[J].Nat Genet,1997,15(4):356-362.
  • 8Pim D,Massimi P,Dilworth S M,et al.Activation of the protein kinase B pathway by the HPV-16 E7 oncoprotein occurs through a mechanism involving interaction with PP2A[J].Oncogene,2005,24(53):7830-7838.
  • 9Ansari-Lari M A,Staebler A,Zaino R J,et al.Distinction of endocervical and endometrial adenocarcinomas:immunohistochemical p16 expression correlated with human papillomavirus DNA detection[J].Am J Surg Pathol,2004,28(2):160-167.
  • 10Clavel C,Masure M,Bory J P,et al.Hybrid Capture Ⅱ-based human papillomavirus detection,a sensitive test to routine high-grade cervical lesions:a preliminary study on 1518 women[J].Br J Cancer,1999,80(9):1306-1311.

共引文献8

同被引文献46

  • 1夏曙,于世英.抑制PI3K/Akt信号转导通路提高化疗效果的实验研究[J].肿瘤,2006,26(4):311-313. 被引量:21
  • 2Tanaka H,Yoshida M,Tanimura H,et al.The selective class Ⅰ PI3K inhibitor CH5132799 targets human cancers harboring oncogenic PIK3CA mutations[J].Clin Cancer Res,2011,17(10):3272-3281.
  • 3German S,Aslam HM,Saleem S,et al.Carcinogenesis of PIK3CA[J].Hered Cancer Clin Pract,2013,11(1):5.
  • 4Jin L,Shen Q,Ding S,et al.Immunohistochemical expression of Annexin A2 and S100A proteins in patients with bulky stage ⅠB-ⅡA cervical cancer treated with neoadjuvant chemotherapy[J].Gynecol Oncol,2012,126(1):140-146.
  • 5Cui B,Zheng B,Zhang X,et al.Mutation of PIK3CA:Possible risk factor for cervical carcinogenesis in older women[J].Int J Oncol,2009,34(2):409-416.
  • 6Goto T,Takano M,Sasa H,et al.Clinical significance of immunocytochemistry for PIK3CA as a carcinogenesis-related marker on liquid-based cytology in cervical intraepithelial neoplasia[J].Oncol Rep,2006,15(2):387-391.
  • 7Wright AA,Howitt BE,Myers AP,et al.Oncogenic mutations in cervical cancer genomic differences between adenoearcinomas and squamous cell carcinomas of the cervix[J].Cancer 2013,119 (21):3776-3783.
  • 8Zhao L,Vogt PK.Helical domain and kinase domain mutations in p110of phosphatidylinositol 3-kinase induce gain of function by different mechanisms[J].Proc Natl Acad Sci USA,2008,105 (7):2652-2657.
  • 9Janku F,Lee JJ,Tsimberidou AM,et al.PIK3CA Mutations Frequently Coexist with RAS and BRAF mutations in Patients with Advanced Cancers[J].PLoS One,2011,6(7):e22769.
  • 10McIntyre JB,Wu JS,Craighead PS,et al.PIK3CA mutational status and overall survival in patients with cervical cancer treated with radical chemoradiotherapy[J].Gynecol Oncol,2013,128 (3):409-414.

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部